このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。 英語版 ソーステキスト用。

LOVING (Learning About Our Behavior is Valuable for Increasing Nurturing Relationships and Healthy Growth) RCT (LOVING)

2026年7月1日 更新者:Anne Rifkin-Graboi、National University of Singapore

LOVING (Learning About Our Behavior is Valuable for Increasing Nurturing Relationships and Healthy Growth)

The LOVING study is a randomized controlled trial designed to determine whether adaptations to an internationally recognized parenting program that enhances sensitive caregiving likewise improves sensitive caregiving in Singapore and, in turn, downstream child outcomes in emotional, behavioral, and cognitive development during the early childhood years.

Research shows that sensitive caregiving is linked to secure relationships, decreased child mental health problems, better executive functioning, and potentially healthier body mass indices. The Video Feedback to Improve Positive Parenting and Sensitive Discipline (VIPP-SD) program is an internationally recognized home-based intervention designed to enhance sensitive caregiving. However, evidence demonstrating its efficacy in Asia remains extremely limited. Moreover, most previous evaluations have focused primarily on parenting or child mental health outcomes, with newer work only beginning to focus upon additional child outcomes.

In this study, families with young children from median-income and below households living in Singapore will be randomly assigned to one of three groups. Some families will participate in a locally adapted version of the home-based VIPP-SD program that includes additional health-related scenarios (VIPP-SD-SingH). Other families will be assigned to CARE-SD, which was developed within the context of proof-of-concept research. CARE-SD is a standardized, digitally delivered parenting program using vicarious pre-rendered video examples and comments derived from the VIPP-SD program and does not include personalized feedback during home visits. Furthermore, CARE-SD includes health related scenarios and language and settings familiar to families living in Singapore. A third group will receive developmental information about children's learning and development (i.e., NeuroEducation Active Control). The programs are brief and are designed to be practical and accessible for families.

Families participating in the study will take part in research visits that include questionnaires, observations of parent-child interaction, and activities designed to assess children's development. Laboratory visits will take place at IHDP (a collaborating institution) research facilities. Information collected in the study will help researchers better understand how parenting support programs influence children's emotional well-being, behavior, learning, and physical health.

The results of this research may help inform the development of effective programs to support families and promote healthy child development.

調査の概要

詳細な説明

Early childhood is a critical developmental period during which caregiving relationships play an important role in shaping children's social, emotional, cognitive, and physical development. Sensitive caregiving occurs when a caregiver accurately perceives and responds to a child's signal in a timely and appropriate manner. It is associated with secure attachment relationships, fewer child behavioral and emotional difficulties, better executive functioning, and potentially healthier physical development.

Interventions that support sensitive caregiving have therefore been identified as promising approaches for promoting healthy child development and preventing later mental health and behavioral problems.

One of the most widely studied programs designed to enhance sensitive caregiving is the Video Feedback to Improve Positive Parenting and Sensitive Discipline (VIPP-SD) program. VIPP-SD is a brief, home-based intervention that uses video feedback to help caregivers recognize and respond sensitively to their child's cues and to support positive discipline practices. Numerous randomized trials conducted primarily in Europe and North America have demonstrated that the VIPP-SD can improve parental sensitivity and, in several cases, child behavioral outcomes. However, rigorous evaluations of these approaches in Asian contexts remain extremely limited. In addition, most existing studies have focused primarily on parenting and child mental health outcomes, with less attention to broader developmental domains such as executive functioning or physical health.

The LOVING study is a randomized controlled trial designed to evaluate whether an adapted version of the VIPP-SD program (i.e., VIPP-SD-SingH, Video-Feedback Intervention to Promote Positive Parenting and Sensitive Discipline Adapted for the Singapore Context with a Health Component), improves sensitive caregiving and downstream child externalizing (specifically conduct and oppositional defiant symptoms). The RCT will also examine additional child developmental outcomes among families in Singapore in a secondary (i.e., children's executive functioning and adiposity) and/or exploratory capacity.

The study will furthermore provide an exploratory proof of principle investigation of whether a standardized, digitally delivered parenting program using vicarious pre-rendered video examples and comments derived from the VIPP-SD program, which does not include personalized feedback during home visits, but like the VIPP-SD-SingH incorporates Singaporean experience and health related contexts, produces benefits relative to an active control. That is, this study's investigations involving CARE-SD (i.e.,Caregiver Awareness of Relationships through E-learning for Sensitivity and Discipline) will provide additional acceptability and feasibility information beyond that obtained in earlier LOVING research and preliminary proof-of-principle efficacy information.

Additional discovery analyses will compare VIPP-SD-SingH versus NeuroEducation Control and CARE-SD versus NeuroEducation Control on other outcomes, as well as mediating and moderating processes, including genetic moderators.

Six-hundred-twenty four parent-young-child pairs from median-income and below households will be recruited and randomly assigned to one of three study groups. Sample size was determined via G-power 3.1 in the following way. First, the minimal sample size needed for the primary confirmatory (VIPP-SD-SingH versus NeuroEducation) outcomes assessed with a repeated measures design and interaction term was calculated. With regards to parental sensitivity, an effect size of f = 0.18 was assumed based on prior meta-analytic data and f = 0.12 was chosen for ODD+CD symptoms in keeping with that reported with similar interview data within HSHS . Using an alpha of .05, correlations between pretest and posttest assessments of r = .30, and power .95, the required dyadic sample size is 72 per arm for parental sensitivity and 159 per arm for oppositional defiant and conduct problems. Assuming a 15 percent drop-out rate the necessary dyadic numbers become 83 and 183.

In addition, G-power 3.1 was also used to calculate the minimal sample size needed for the secondary confirmatory (VIPP-SD-SingH versus NeuroEducation) analyses. Given the comparatively limited literature base, rather than relying on past published effect sizes, f = 0.10 was chosen as a reasonable estimate for behavioral interventions. Using an alpha of .025 (i.e., corrected for the two secondary outcomes [i.e., MEFS performance & BMIz]), correlations between pretest and posttest assessments of r = .30, and power .80, the required dyadic sample size is 168 per arm, which becomes 194 after adjusting for a 15% drop-out rate.

Considering the parallel exploratory analyses requiring the additional CARE-SD arm, the total sample size should be minimally 249 (parental sensitivity), 548 (ODD and CD symptoms), and 582 (adiposity and executive functioning ). As such, even with the addition of covariates, the anticipated sample size of 624 dyads should be sufficient to detect primary and secondary confirmatory outcomes.

Participating families will complete research visits that include questionnaires, structured observations of parent-child interaction, hair samples for hormonal analyses, buccal cell swabs for genetic moderation, electrophysiology and assessments of children's development including executive functioning, emotional memory, and physical fitness. These assessments will allow for explorations of whether the interventions improve parenting sensitivity and child outcomes and whether changes in caregiving are associated with improvements in children's emotional, behavioral, cognitive, and physical outcomes.

Upon trial completion an exploratory cost effectiveness analysis of the VIPP-SD-SingH program versus NeuroEducation will be conducted. Findings from the LOVING trial will contribute to the limited evidence base on parenting interventions in Asian populations and will help inform the development of alternative approaches to support families and promote healthy child development in Singapore and similar contexts.

研究の種類

介入

入学 (推定)

624

段階

  • 適用できない

連絡先と場所

このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。

研究連絡先

  • 名前:Christy Yifan Jiang, PhD
  • 電話番号:80695639
  • メール:jyifan@nus.edu.sg

研究連絡先のバックアップ

研究場所

    • Singapore
      • Singapore、Singapore、シンガポール、117609
        • 募集
        • Insitute of Human Development and Potential, Agency for Science and Technology Research (A*STAR)
      • Singapore、Singapore、シンガポール、11907
        • 募集
        • National University of Singapore
      • Singapore、Singapore、シンガポール、229899
        • 募集
        • KK Women and Children's Hospital
      • Singapore、Singapore、シンガポール、637616
        • 募集
        • National Institute of Education, Nanyang Technological University
      • Singapore、Singapore、シンガポール、639798
        • 募集
        • Nanyang Technological University

参加基準

研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。

適格基準

就学可能な年齢

  • 子
  • 大人
  • 高齢者

健康ボランティアの受け入れ

はい

説明

Children must be 2 to 5.5 years of age at their pre-test visit. Children with a medical or developmental condition that makes it hard for them to see, hear, move, or communicate in typical ways (for example, autism spectrum disorder, down syndrome, spina bifida, or serious vision or hearing problems) will not be eligible to participate. This is because the study focuses on everyday patterns of parent-child interaction. Children with minor or symptom-free medical or genetic conditions (for example, traits that do not affect their day-to-day health or development) can take part.

Parents must be between 21 and 65 years old at the time of consent. Mothers and fathers who consider themselves to have a major caregiving role are eligible. Parents who have been hospitalized for more than two weeks (inclusive) within the past 6 months and/or have had any in-patient mental health treatment within the past 6 months may not participate, nor may parents with notable neurodegenerative diagnosis such as Alzheimer's, Parkinson's, or Huntington's disease.

Participants must be from families earning near to Singapore's median household income or below, provided recruitment and enrollment difficulties have not triggered a pre-defined rule leading to the omission of this requirement. Parents and children must be able to communicate in English, Mandarin, Bahasu Melayu, and/or Tamil. Participants must also be willing to be audio-video recorded and amenable to random assignment.

研究計画

このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。

研究はどのように設計されていますか?

デザインの詳細

  • 主な目的:防止
  • 割り当て:ランダム化
  • 介入モデル:並列代入
  • マスキング:ダブル

武器と介入

参加者グループ / アーム
介入・治療
実験的:VIPP-SD-SingH

Participants assigned to this arm will receive the VIPP-SD-SingH program. Both adult and child participants will actively take part in at least some aspects of the VIPP-SD-SingH.

Each VIPP-SD-SingH session is scheduled as close to 14 days after the prior home-visit as possible. Participants will not progress to the next VIPP-SD-SingH session if they have not completed the prior one. However, the maximum duration for the intervention will be 32 weeks.

The VIPP-SD-SingH is an adaptation of the seven session home-visiting VIPP-SD program. During the first six VIPP-SD sessions the parent-child dyad will be asked to take part in certain activities together while being recorded. During sessions 2-7 the parent will watch the prior sessions's videos and receive frequent (e.g., 10-30 second) feedback ( e.g., focusing on children's perspectives, awareness of attachment and explorative child behavior, tips for sensitive discipline, and back-and-forth behavior). The VIPP-SD-SingH will include some adjustments for local language use and VIPP-SD compatible stimulation for reflections on tips and activities that allow greater generalization of the VIPP-SD principles to physical health contexts (e.g., waiting to eat a snack, using toys that encourage movement, or activities that may encourage relaxation).
他の名前:
  • This was referred to as "O" or "Own" during earlier LOVING Development/Pilot research.
他の:CARE-SD

Participants assigned to this arm will receive the CARE-SD program for proof of principle, implying whatever the outcome further tests are indispensable for translation to policy or practice. Results will further inform feasibility/acceptability and preliminarily efficacy information.

Parents will be asked to watch online CARE-SD sessions and then involve children in activities. After session videos have been opened, participants can mark a session as complete. Then, the completed session's materials will remain accessible for 14 days. Marking a session "complete" also triggers the next session to open 14 days later. User metrics and additional self-reported involvement data (e.g., How much did you watch? Did you do the activities?) will be collected, but will not influence the first-level assessment of completion (for Intent to Treat analyses) or session progression. Participants will not progress without completing prior sessions, though the maximum duration will be 32 weeks.

CARE-SD, Caregiver Awareness of Relationships through E-learning for Sensitivity and Discipline was developed within the context of proof-of-concept research. CARE-SD is a standardized, digitally delivered parenting program using vicarious pre-rendered video examples and comments derived from the VIPP-SD program and does not include personalized feedback during home visits. Furthermore, CARE-SD includes health related scenarios and language and settings familiar to families living in Singapore. As with the VIPP-SD-SingH, CARE-SD's design includes seven sessions with scenarios and comments for generalizability to physical activity, feeding, and relaxation. After watching each of the videos in sessions 2-7, parents will be asked to try out the activities they've viewed with their own child. Instructions and suggestions for materials will be provided as will be questions for reflection.
他の名前:
  • This was referred to as "V" or "Vicarious" in LOVING Developmental/Pilot research.
他の:NeuroEducation for Parents

This arm will serve as an Active Control for both VIPP-SD-SingH and CARE-SD. It is not expected to notably impact sensitive caregiving though it may impact caregiver knowledge about child development.

After a sessions' videos have been opened, participants will have access to a form where they can mark a session as complete. Once they do so, the completed session's materials will remain accessible for 14 days. Marking a session as "complete" also triggers the next session to open 14 days later. Although user metrics and additional self-reported involvement data (e.g., How much did you watch? Did you read the additional material?) will be collected, those will not influence the first-level assessment of completion (for Intent to Treat analyses) or session progression.

People will not progress to the next NeuroEducation session if they have not completed the prior one. However, the maximum duration for the intervention will be 32 weeks.

NeuroEducation for Parents was designed as a seven session online program for parents containing informational videos about young children's Brain Basics, Seven Senses, Learning and Memory, Emotion, Curiosity and Creativity, Thinking, and Friendships. Sensitive caregiving is not discussed explicitly. Each session will end with a short video quiz, complete with answers. Additional optional written material will be provided for parents who wish to learn more.
他の名前:
  • This was referred to as "E" or "neuroEducation" in LOVING Developmental/Pilot research.

この研究は何を測定していますか?

主要な結果の測定

結果測定
メジャーの説明
時間枠
Differential Change Pre-Post Parental Sensitivity Assessed via the Preschool MBQS (Parent Outcome) Confirmatory: VIPP-SD-SingH more favorable trajectory than NeuroEducation; Exploratory: CARE-SD more favorable trajectory than NeuroEducation
時間枠:Prior to revealing the Treatment Arm until One to Three Months Post Last Intervention Session
Change in parental sensitivity will be evaluated from video records of four dyadic interactions, totaling roughly 25 minutes of behavior per relevant lab visit. Trained coders will apply the Preschool MBQS (Pederson et al, 2013; Tarabulsy 2009), a 25-item forced q-sort to interactions. The interactions themselves will proceed in a set order beginning with a parent-child snack, obedience task, hopscotch-like game, and sticker-by-art activity. These will be included for relevance to obedience and the physical health related aspects in the VIPP-SD-SingH and CARE-SD programs (i.e., feeding/nutrition; physical activity/movement; rest/relaxation). Tasks are likely amenable to engaged interaction but also do not explicitly require it. Instructions will be delivered on notecards, to ensure consistency and also some divided attention. In principle, all tasks can be conducted in a developmentally appropriate manner. 20% will be independently coded.
Prior to revealing the Treatment Arm until One to Three Months Post Last Intervention Session
Differential Change in Pre-Post PAPA Assessed ODD/Conduct Symptom Count (Child Outcome) Confirmatory: VIPP-SD-SingH more favorable trajectory than NeuroEducation; Exploratory: CARE-SD more favorable trajectory than NeuroEducation
時間枠:Prior to revealing the Treatment Arm until One to Three Months Post Last Intervention Session
Parents will be interviewed by trained staff using modules from the "The Preschool Age Psychiatric Assessment (PAPA): A structured parent interview for diagnosing psychiatric disorders in preschool children" (see Egger et al., 2019). The outcome used in primary analyses will be the sum of the Oppositional Defiant Disorder (ODD) and Conduct Problems (CD) symptom counts (maximum score = 17). ODD symptoms will be assessed with regards to a "primary period" (e.g., 3 months) and require a minimal frequency to be met, which varies by symptom and is adjusted by age (as per the DSM5). CD symptom criteria are more varied, with some variables requiring only one occurrence, which in some cases can happen outside the primary period. In such cases, we will also collect occurrence within the last three months to better examine intervention effects. Note: The minimal time between Labs 1 and 3 will be 18 weeks, i.e., more than 3 months. 20% of interviews will contribute to fidelity checks.
Prior to revealing the Treatment Arm until One to Three Months Post Last Intervention Session

二次結果の測定

結果測定
メジャーの説明
時間枠
Differential Change in Pre-Post Adiposity Assessed by Body Mass Index z-score (BMIz) (Child Outcome) Confirmatory: VIPP-SD-SingH more favorable trajectory than NeuroEducation; Exploratory: CARE-SD more favorable trajectory than NeuroEducation
時間枠:Prior to revealing the Treatment Arm until One to Three Months Post Last Intervention Session
Change in child adiposity will be evaluated using body mass index z-score (BMIz). Weight and height measurements will be obtained by trained study staff using standardized anthropometric procedures. These measurements will be used to calculate BMI as weight (kg) divided by height (m²), which will then be converted to an age- and sex-specific BMI z-score (BMIz) using established reference standards. Weight and height will not be analyzed as separate outcome measures.
Prior to revealing the Treatment Arm until One to Three Months Post Last Intervention Session
Differential Change in Pre-Post Child Executive Functioning as Assessed via the MEFS. Confirmatory: VIPP-SD-SingH more favorable trajectory than NeuroEducation; Exploratory: CARE-SD more favorable trajectory than NeuroEducation
時間枠:Prior to revealing the Treatment Arm until One to Three Months Post Last Intervention Session
Child executive functioning (EF) will be assessed using the Minnesota Executive Function Scale (MEFS; Carlson & Zelazo, 2014, 2021). The MEFS will be administered individually by trained staff. The MEFS consists of an adaptive virtual sorting task that provides a brief composite measure of EF. The assessment was designed for use across a wide range of ability levels, with task difficulty adjusted across seven levels based on the child's performance. MEFS Total Scores will be used to summarize EF, with higher scores indicating better EF.
Prior to revealing the Treatment Arm until One to Three Months Post Last Intervention Session

その他の成果指標

結果測定
メジャーの説明
時間枠
Additional Exploratory Outcomes, Mediators, and Moderators
時間枠:All laboratory pre-tests are prior to random assignment being revealed. Some measures are then also assessed whilst the treatments are ongoing, others 1-3 months after the last session, and others 6 or 12 months following the final treatment session.

The following are a) exploratory outcomes evaluated as pre-post differential change, favoring the intervention(s) over the Neuroeducation control; and/or b) exploratory mediators/moderators:

  1. Child Fitness: PreFit Tests (e.g., balance, 10m, long-jump)
  2. Child Diet Quality: Reported frequencies of food groups
  3. Parent Reported Child Psychosocial Fn and/or Executive Control: CBCL Internalizing, CBCL Attentional Problems, BRIEF-P
  4. Parent Reported Feeding and Activity: Feeding Practices, PREPAQ
  5. Parent Self-Reported Parenting: IM-P (mindfulness); PSDQ (parenting styles); Parenting Growth Mindset
  6. Parent Self Reported Mental Health (DASS-21) and Executive Functioning (ADEXI)
  7. Additional Measures of Observed Parenting
  8. Cortisol from Hair
  9. EEG Power/Asymmetry during resting and cognitive tasks
  10. Emotional Memory
  11. Genetic Moderation (e.g., SLC6A3 ePGS; ENVResp-ePGS)
  12. Child Development/Brain Knowledge (expected to favor the NeuroEducation Control group)
All laboratory pre-tests are prior to random assignment being revealed. Some measures are then also assessed whilst the treatments are ongoing, others 1-3 months after the last session, and others 6 or 12 months following the final treatment session.

協力者と研究者

ここでは、この調査に関係する人々や組織を見つけることができます。

出版物と役立つリンク

研究に関する情報を入力する責任者は、自発的にこれらの出版物を提供します。これらは、研究に関連するあらゆるものに関するものである可能性があります。

一般刊行物

研究記録日

これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。

主要日程の研究

研究開始 (実際)

2026年5月25日

一次修了 (推定)

2028年2月9日

研究の完了 (推定)

2028年2月9日

試験登録日

最初に提出

2026年5月24日

QC基準を満たした最初の提出物

2026年7月1日

最初の投稿 (実際)

2026年7月7日

学習記録の更新

投稿された最後の更新 (実際)

2026年7月7日

QC基準を満たした最後の更新が送信されました

2026年7月1日

最終確認日

2026年7月1日

詳しくは

本研究に関する用語

個々の参加者データ (IPD) の計画

個々の参加者データ (IPD) を共有する予定はありますか?

未定

IPD プランの説明

Sharing will need to be evaluated on a case-by-case basis in order to comply with participants' informed consent choices as well as local and institutional policies.

医薬品およびデバイス情報、研究文書

米国FDA規制医薬品の研究

いいえ

米国FDA規制機器製品の研究

いいえ

この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。

購読する